Navigation Links
Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival

A significant improvement in the survival rates has been documented in Acute Coronary Syndrome patients, instituted aggressive statin therapy, based on a analysis reported at the Society for Cardiovascular Angiography and Interventions (SCAI) // 29th Annual Scientific Sessions in Chicago, May 10–13.

By combining data from nine randomized clinical trials and evaluating clinical outcomes individually rather than in combination, the analysis was able to put a sharper focus on the benefits of early statin therapy.

‘We found that there was a benefit in what matters most--survival,’ said Anthony Bavry, MD, a fellow in cardiovascular medicine at the Cleveland Clinic Foundation in Cleveland, OH.

The study involved data from more than 16,000 patients admitted to the hospital with ACS, a term that encompasses both unstable chest pain, or angina, and a particular form of heart attack. In each of the original studies, patients were randomly assigned to maximal-dose statin therapy during the hospital stay or to a more conservative approach that consisted of low-dose statin therapy or placebo.

Statins are primarily used to lower cholesterol levels in the blood, but they have other effects as well, including the ability to reduce inflammation in the arteries.

Dr. Bavry and his colleagues found that early, aggressive statin therapy reduced the risk of death by 22 percent and the risk of cardiovascular death by 25 percent, over a follow-up that averaged 15 months. Further analysis showed that for every 111 patients who were treated with early statin therapy, one life could be saved.

In addition, early statin therapy reduced the risk of another episode of unstable angina by 17 percent and the need to open a blocked coronary artery with a catheter-based procedure or coronary bypass surgery by 9 percent.

The improvement in survival was noticeable early on but became statistically certain only after six months of
'"/>




Page: 1 2

Related medicine news :

1. Statins reduce heart attacks
2. Statins reduce risks for angioplasty patients
3. Statins Found To Be Helpful For Patients With Arthritis
4. Long-Term Benefits Of Statins Questioned
5. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
6. Use of Statin can help in recovery from stroke
7. Statins Not Effective In Treating Calcific Aortic Stenosis
8. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
9. The Effects of Statins Questioned
10. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
11. Study Finds No Link Between Statins And Breast Cancer Risk
Post Your Comments:
(Date:8/29/2008)...e/ -- The following is a,statement by Matthew L. M... For the second time in a month, Philip Morris Int...motion of a concert in a developing country,after ...in cigarette,marketing that appeals to children., ...orced to withdraw from,an August 30 reunion concer...
(Date:8/29/2008)...n response to recent news,about Michigan,s first i...embers of the deer farming community have issued t... approaching, the tragic incident regarding a,CWD ...erstandably has,created concern among hunters, out... state of Michigan. The deer farming industry in M...
(Date:8/29/2008)...ed in the August 28 issue of the New England Jour...nistered to women delivering before 32 weeks of ge...ercent. The Beneficial Effects of Antenatal Magnes...rs in the U.S., including Northwestern Memorial, a...o reduce the instance of cerebral palsy related to...
(Date:8/29/2008)...e software provider allows federal, state, and loc... Reston, VA (PRWEB) August 29, 20...ring firm dedicated to the life sciences, announce...ion (GSA) Contract. The GSA IT Schedule 70 provide...ently engage 5AM Solutions, software services. The...
Breaking Medicine News(10 mins):Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2
...ntion deficit hyperactivity disorder drugs should ...ehavior, heart problems and sudden death, accordin...ugs include Novartis AG's Ritalin and GlaxoSmithKl...Drug Administration spokeswoman, Susan Bro said. ...
...obia or fear of needles can be overcome by decorat...es according to researchers at the University of N...searchers say that fear of needles can impact the ... become hysterical at the sight of needles, wherea...
...ports from UK indicate that increasing numbers of ...not receiving enough support.// The study also fo... the homeless people of the ages 16-25 of homeless...he report that was titled 'Making the Link between...
...dea to provide health services at supermarkets has... that class of patients who simply hate waiting. T...ditions like flu, bladder infections and sprains. ...to introduce such clinics at Walgreens drugstores ...
Other Medicine News:Health News:New Alerts Needed for ADHD drugs 2
(Date:8/27/2008)...FirstCall/ --, - Oralair(R) Grasses 300IR Highly ...dy Conducted in an Allergen Challenge Chamber, St...lts of a new study,conducted in an Allergen Challe...es included 86 adult patients exposed to,grass pol...1 week, 1 month,2 and 4 months without a titratio...
(Date:8/26/2008)...Semafore Pharmaceuticals Inc.,announced data prese...eted,Therapies in Cancer in Washington, D.C., show...-targeted PI3 kinase (PI3K) inhibitor SF1126, by,b...t of a very powerful pathway, the PI3/AKT /mTOR pa...cancer. Studies have shown that by,inhibiting this...
(Date:8/26/2008)...e-FirstCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today...ta,from the CUSTOM II trial was published in the m...oIntervention. The lead author of the article was,...Center Utrecht, Utrecht,The Netherlands on behalf...ites across Europe., The one-year CUSTOM II trial...
(Date:8/25/2008)...swire/ -- Joseph F. Finn, Jr.,C.P.A. ("Finn"), As...) for,the benefit of creditors, announced today th...e sold at a sealed bid auction on October 10,2008...Levodopa-Carbidopa that,is the current gold standa...sales estimated at approximately $250 million. Sig...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisas Legacy Fund for Cancer Research and Education 2587 1University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisas Legacy Fund for Cancer Research and Education 2587 2University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisas Legacy Fund for Cancer Research and Education 2587 3University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisas Legacy Fund for Cancer Research and Education 2587 4Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of Amer 984 1Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of Amer 984 2Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of Amer 984 3From microscope to stethoscope 3A The MUHCs public lecture series begins its 2nd season tomorrow 2584 1InfoLogix Acquires Healthcare Informatics Associates Inc 28HIA 29 3B Adds Premier Healthcare Consulting Firm and Systems Integrator 2582 1InfoLogix Acquires Healthcare Informatics Associates Inc 28HIA 29 3B Adds Premier Healthcare Consulting Firm and Systems Integrator 2582 2InfoLogix Acquires Healthcare Informatics Associates Inc 28HIA 29 3B Adds Premier Healthcare Consulting Firm and Systems Integrator 2582 3InfoLogix Acquires Healthcare Informatics Associates Inc 28HIA 29 3B Adds Premier Healthcare Consulting Firm and Systems Integrator 2582 4
... African-Americans with Family History of ESRD Ar...proximately ten percent of U.S.,adults have a fami...these individuals appear to be at increased risk o...study in the April Journal of,the American Society...ase is more frequent in,African-Americans, who are...
... - Anti-IL-2 receptor antibody significantly reduc...to placebo; data to be submitted,for presentation ...d FREMONT, Calif., March 12, 2007,/PRNewswire-Firs....,(PDL) announced today that the ongoing CHOICE tr...controlled trial of daclizumab,met its primary en...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 4Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 5
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: